Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ADYXOTCMKTS:CTTCOTCMKTS:DXTRQOTCMKTS:RGIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADYXAlliqua BioMedical$0.00$0.00▼$0.00N/A2.0524 shsN/ACTTCCompetitive Technologies$0.00$0.00▼$0.02N/AN/AN/AN/ADXTRQDextera Surgical$0.03$0.03$0.02▼$0.16N/AN/AN/AN/ARGINRegenicin$0.00$0.00▼$0.00$20KN/A35,003 shsN/A10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADYXAlliqua BioMedical0.00%0.00%0.00%0.00%0.00%CTTCCompetitive Technologies0.00%0.00%0.00%0.00%0.00%DXTRQDextera Surgical0.00%0.00%0.00%0.00%0.00%RGINRegenicin0.00%0.00%0.00%0.00%-98.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADYXAlliqua BioMedicalN/AN/AN/AN/AN/AN/AN/AN/ACTTCCompetitive TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ADXTRQDextera SurgicalN/AN/AN/AN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADYXAlliqua BioMedical 0.00N/AN/AN/ACTTCCompetitive Technologies 0.00N/AN/AN/ADXTRQDextera Surgical 0.00N/AN/AN/ARGINRegenicin 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADYXAlliqua BioMedicalN/AN/AN/AN/AN/AN/ACTTCCompetitive TechnologiesN/AN/AN/AN/AN/AN/ADXTRQDextera SurgicalN/AN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADYXAlliqua BioMedicalN/AN/A0.00N/AN/AN/AN/AN/AN/ACTTCCompetitive TechnologiesN/AN/A0.00N/AN/AN/AN/AN/AN/ADXTRQDextera SurgicalN/AN/A0.00∞N/AN/AN/AN/AN/ARGINRegenicin-$640KN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADYXAlliqua BioMedicalN/AN/AN/AN/AN/ACTTCCompetitive TechnologiesN/AN/AN/AN/AN/ADXTRQDextera SurgicalN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADYXAlliqua BioMedicalN/ACTTCCompetitive TechnologiesN/ADXTRQDextera SurgicalN/ARGINRegenicin0.01%Insider OwnershipCompanyInsider OwnershipADYXAlliqua BioMedical17.40%CTTCCompetitive Technologies17.50%DXTRQDextera Surgical10.43%RGINRegenicinN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADYXAlliqua BioMedical6N/AN/ANot OptionableCTTCCompetitive Technologies7N/AN/ANot OptionableDXTRQDextera SurgicalN/AN/AN/ANot OptionableRGINRegenicin3165.77 millionN/ANot OptionableRGIN, ADYX, CTTC, and DXTRQ HeadlinesRecent News About These CompaniesHistoryOctober 20, 2024 | npr.orgShaun Micallef's Origin OdysseyOctober 18, 2024 | sbs.com.auRegenicin, Inc. (RGIN)September 5, 2024 | finance.yahoo.comThe Cambridge World History of SlaveryAugust 20, 2024 | cambridge.orgThe Cambridge Ancient HistoryAugust 3, 2024 | cambridge.orgHow to watch State of Origin overseas: International broadcasters, TV channels, live streams, timesJuly 19, 2024 | sportingnews.comState of Origin: When and where is Origin in 2024?May 21, 2024 | sportingnews.comLGBT+ History Month - Teaching ResourcesMay 3, 2024 | bbc.co.ukHistory & TraditionApril 20, 2024 | smith.eduSevere cold front hits central, eastern regions; schools forced to delay start of new semesterFebruary 21, 2024 | globaltimes.cnPalworld map – all locations, regions, and points of interestFebruary 2, 2024 | pcgamesn.comAlexander boys fend off top challenger in Region 5January 30, 2024 | ajc.comJohn Kerry praises Biden for preventing 'uncontrolled war in many regions'January 20, 2024 | foxnews.comJournal of the History of Economic ThoughtJanuary 7, 2024 | cambridge.orgHistory of computers: A brief timelineDecember 24, 2023 | livescience.comWATCH: Blue Origin successfully launches rocket in first flight since 2022 crashDecember 21, 2023 | wlwt.comBlue Origin successfully completes rocket mission more than a year after failed launchDecember 21, 2023 | nydailynews.comBlue Origin launches New Shepard rocket, aces landing in 1st return to flight since 2022 failure (video)December 20, 2023 | space.comJeff Bezos’ Blue Origin puts a hold on its first suborbital space launch in 15 monthsDecember 20, 2023 | geekwire.comHistory of Walmart: Timeline and FactsDecember 9, 2023 | thestreet.comTop HeadlinesView All HeadlinesWorkday Stock Price Implosion: An Automatic Buy for AI InvestorsBy Thomas Hughes | May 26, 2025View Workday Stock Price Implosion: An Automatic Buy for AI InvestorsGitLab: Buy It Low While You Still Can—Higher Prices Are ComingBy Thomas Hughes | June 11, 2025View GitLab: Buy It Low While You Still Can—Higher Prices Are Coming$30B AI Opportunity: Will It Power Meta’s Next Surge?By Leo Miller | May 21, 2025View $30B AI Opportunity: Will It Power Meta’s Next Surge?Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?By Jeffrey Neal Johnson | May 22, 2025View Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?Rivian Stock Below $20: Charging Up or in the Breakdown Lane?By Jeffrey Neal Johnson | May 21, 2025View Rivian Stock Below $20: Charging Up or in the Breakdown Lane?RGIN, ADYX, CTTC, and DXTRQ Company DescriptionsAlliqua BioMedical OTCMKTS:ADYXAdynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.Competitive Technologies OTCMKTS:CTTCCalmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.Dextera Surgical OTCMKTS:DXTRQ$0.03 0.00 (0.00%) As of 12/4/2018Dextera Surgical Inc. designs and manufactures proprietary stapling devices for surgical procedures. The company's product consists of MicroCutter 5/80 use for transection and resection in urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the intestine and the transection of the appendix. Dextera Surgical Inc., formerly known as Cardica Inc., is headquartered in Redwood City, California.Regenicin OTCMKTS:RGINRegenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
